ASHLEY HUDDLESTUN: Open Payments
NPI 1083339642 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 20 payments from 10 companies in 2025. Trend: 2023 $454 · 2024 $576 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| ABBVIE INC. | 2 | $38 |
| Lilly USA, LLC | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: OTEZLA, BREZTRI, INGREZZA, CAPLYTA, VRAYLAR, MOUNJARO, GVOKE HYPOPEN, Ozempic.
Industry payments across IL — which companies pay providers there.
